1. DDIS-04. COMPOUNDS IDENTIFIED BY STRUCTURE BASED VIRTUAL SCREENING DECREASE GBM BTIC GROWTH AND GLUCOSE UPTAKE. (5th November 2018) Authors: Libby, Catherine; Zhang, Sixue; Gc, Sajina; Benavides, Gloria; Scott, Sarah; Pathak, Vibha; Moukha-Chafiq, Omar; Li, Yanjie; Redmann, Matthew; Tran, Anh; Otamias, Arphaxad; Darley-Usmar, Victor; Napierala, Marek; Zhang, Jianhua; Augelli-Szafran, Corinne; Zhang, Wei; Hjelmeland, Anita Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DDIS-24. DECREASE IN GLIOBLASTOMA GROWTH IN VITRO WITH TREATMENT OF NOVEL ANALOGS OF GLUCOSE TRANSPORTER INHIBITORS. (11th November 2019) Authors: GC, Sajina; Libby, Catherine; Zhang, Sixue; Benavides, Gloria; Scott, Sarah; Li, Yanjie; Tran, Anh; Otamias, Arphaxad; Darley-Usmar, Victor; Napierala, Marek; Pathak, Vibha; Moukha-Chafiq, Omar; Augelli-Szafran, Corinne; Zhang, Wei; Hjelmeland, Anita Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development of novel small molecules for the treatment of ALS. Issue 4 (15th February 2020) Authors: Mathew, Bini; Ruiz, Pedro; Pathak, Vibha; Suto, Mark J. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 30:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development of small‐molecule tau‐SH3 interaction inhibitors that prevent amyloid‐β toxicity. (31st December 2021) Authors: Roth, Jonathan R; Rush, Travis; Pugh, Derian A; Dean, Hunter B; Cochran, J. Nicholas; Thompson, Samantha J; Aldaher, Adam R; Mesina, Jacob S; Ruiz, Pedro; Pathak, Vibha; Wu, Mousheng; Bostwick, J Robert; Suto, Mark J; Augelli‐Szafran, Corinne E; Roberson, Erik D. Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. RETRACTED: SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells. (28th March 2017) Authors: Li, Yonghe; Oliver, Patsy G.; Lu, Wenyan; Pathak, Vibha; Sridharan, Sivaram; Augelli-Szafran, Corinne E.; Buchsbaum, Donald J.; Suto, Mark J. Journal: Cancer letters Issue: Volume 389(2017) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Retraction notice to "SRI36160 is a specific inhibitor of Wnt/<beta>-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41–48]. (28th May 2018) Authors: Li, Yonghe; Oliver, Patsy G.; Lu, Wenyan; Pathak, Vibha; Sridharan, Sivaram; Augelli-Szafran, Corinne E.; Buchsbaum, Donald J.; Suto, Mark J. Journal: Cancer letters Issue: Volume 422(2018) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells. (28th March 2017) Authors: Li, Yonghe; Oliver, Patsy G.; Lu, Wenyan; Pathak, Vibha; Sridharan, Sivaram; Augelli-Szafran, Corinne E.; Buchsbaum, Donald J.; Suto, Mark J. Journal: Cancer letters Issue: Volume 389(2017) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗